The MHRA's raid follows an uptick in the trade of illegal GLP-1RA drugs used for obesity and type 2 diabetes amid shortages ...

Dupixent’s Q3 sales increased by 26.2%, breaking through the €4bn ceiling for the first time in a single quarter.

Immunotherapy drugs continue to gain momentum across a growing range of disease areas with blockbusters such as Merck’s ...

A report by GlobalData revealed that the biotech industry witnessed a 70.9% increase in total venture financing deal value.

GSK has received US Food and Drug Administration (FDA) approval for Blenrep to be used along with BVd for multiple myeloma.

Roche’s CEO Thomas Schinecker said the drugmaker is continuing talks with the US government over drug pricing reforms, as ...

Early-stage equity raises for biotechs surged by 71% in Q3 2025, hinting that the funding freeze that has gripped the ...

Ipsen is set to purchase all issued and outstanding shares of the French biotech company ImCheck Therapeutics.

Remote monitoring technologies offer a vital option for people with diabetes to manage their conditions, with tech developed ...

EUROAPI has announced Med4Cure, an initiative within the Health Important Project of Common European Interest (IPCEI) ...

Alkermes has agreed to acquire Avadel Pharmaceuticals for up to $20 per share in cash, valuing Avadel at $2.1bn. The ...